Agrigenomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Purpose (DNA Extraction & Purification, DNA/RNA Sequencing, Genotyping, Gene Expression Profiling, GMO/Trait Purity Testing, Others), By Sequencer Type (Sanger Sequencing, Pacbio Sequencers, Solid Sequencers, Illumina HI SEQ Family, Others), By Application (Livestock and Crops), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 4.39 Billion
CAGR (2026-2031)	9.02%
Fastest Growing Segment	DNA/RNA Sequencing
Largest Market	North America
Market Size (2031)	USD 7.37 Billion

Market Overview

The Global Agrigenomics Market is expected to grow from USD 4.39 Billion in 2025 to USD 7.37 Billion by 2031 at a 9.02% CAGR. Agrigenomics is defined as the application of genomic technologies, such as high-throughput sequencing and genotyping, to agricultural organisms to enhance traits like yield, disease resistance, and environmental resilience. The market is primarily propelled by the escalating global demand for food security, the imperative to develop climate-smart crops capable of withstanding extreme weather, and the rapidly decreasing costs of DNA sequencing which democratizes access to advanced breeding tools. These drivers collectively foster a robust environment for technological adoption, enabling the rapid development of superior crop and livestock varieties.

However, a significant challenge impeding broader market expansion is the complex and fragmented regulatory landscape, which varies drastically across regions and delays the commercialization of new products. Despite these hurdles, the sector demonstrates immense economic potential; according to the Biotechnology Innovation Organization, in 2025, the direct economic impact of the U.S. bioeconomy across food, agriculture, and manufacturing was valued at $210 billion. This indicates that while compliance remains a barrier, the underlying economic value of biotechnological applications continues to drive substantial industry growth.

Key Market Drivers

Rapid technological advancements in next-generation sequencing and gene editing are the primary engines propelling the Global Agrigenomics Market, enabling the precise modification of crop genomes to enhance productivity. This shift toward high-tech breeding is evident in the robust development pipelines of major industry players who are leveraging genomic insights to create superior seed varieties. For instance, according to BASF, February 2025, in the 'Agricultural Solutions Report 2024', the company's innovation pipeline boasts a peak sales potential of more than €7.5 billion, driven significantly by next-generation traits and crop protection solutions. Underscoring the critical infrastructure supporting these technological advancements, according to Illumina, February 2025, the company reported full-year 2024 revenue of $4.37 billion, highlighting the substantial market scale for the sequencing tools that underpin modern agricultural research.

Simultaneously, the rising necessity for climate-resilient and disease-resistant crop varieties is accelerating market adoption as farmers face increasingly volatile environmental conditions. Agrigenomics allows for the rapid identification and integration of genes responsible for drought tolerance and pest resistance, ensuring food security in a changing climate. This demand for resilience is translating into significant commercial output; according to Corteva Agriscience, November 2024, in its '2024 Investor Day' presentation, the company has launched approximately 2,000 new products over the past five years, a strategic expansion focused on helping farmers mitigate yield losses from extreme weather and biological threats.

Download Free Sample Report

Key Market Challenges

The complex and fragmented regulatory landscape acts as a significant restraint on the Global Agrigenomics Market, directly impeding the efficiency and speed of product commercialization. Because regulatory frameworks differ drastically across national borders, companies are forced to navigate a disjointed global system where a genomic trait approved in one region may be rejected or stalled in another. This lack of harmonization necessitates duplicative testing and documentation, which diverts substantial capital away from research and development. Consequently, the financial burden of compliance creates a high barrier to entry, often discouraging smaller biotechnology firms from entering the market and limiting innovation to major crops where returns are guaranteed.

These regulatory hurdles extend development timelines significantly, delaying the introduction of climate-resilient and high-yield crop varieties that are essential for market growth. According to the American Seed Trade Association, in 2025, the process to commercialize a single new biotech plant product could cost more than $100 million and take a decade or longer to complete. Such extended timelines reduce the immediate return on investment for agribiotech companies and slow the sector's ability to respond dynamically to evolving environmental threats. This environment of uncertainty and high cost fundamentally restricts the market's expansion by preventing rapid technological adoption.

Key Market Trends

The Integration of Artificial Intelligence and Machine Learning for Predictive Breeding is fundamentally reshaping the agrigenomics landscape by shifting the focus from mere data generation to high-precision predictive modeling. Instead of relying on time-consuming multi-generational field trials, seed companies are now utilizing advanced algorithms to analyze vast genomic datasets and predict complex phenotypic traits such as drought tolerance and nutrient use efficiency with unprecedented accuracy. This technological convergence allows for the rapid identification of optimal genetic combinations, significantly shortening development cycles for new commercial varieties. The scale of investment in these R&D capabilities is substantial; according to Bayer Global, November 2025, in the 'Science Research and Innovation' update, the company spent €5.86 billion on research and development in 2024, highlighting the massive capital allocation towards these data-driven breeding pipelines.

Concurrently, the Application of Genomic Tools for Livestock Methane Reduction and Sustainability is emerging as a critical trend, driven by the global imperative to lower the environmental footprint of animal agriculture. Genomic selection is increasingly being utilized not just for productivity traits like weight gain, but specifically to identify and propagate animals with naturally lower methane emission profiles and superior feed conversion rates. This approach enables the livestock sector to meet stringent climate goals while maintaining profitability through scientifically validated genetic improvements. The commercial viability of this segment is evidenced by the strong performance of market leaders; according to Zoetis, February 2025, in the '2024 Annual Report', the company reported full-year 2024 revenue of approximately $9.3 billion, underscoring the robust market demand for advanced animal health and genetic solutions that align with modern sustainability standards.

Segmental Insights

The DNA/RNA sequencing segment is emerging as the fastest-growing component of the global agrigenomics market, driven by the intensifying demand for high-quality crop and livestock production. This expansion is primarily facilitated by the decreasing costs of sequencing technologies, which allow for the efficient detection of genetic traits associated with yield and disease resistance. Consequently, agricultural biotechnology firms utilize these sequencing methods to enhance precision breeding and streamline trait selection processes. This widespread adoption underscores the pivotal role of genomic data in addressing global food security challenges.

Regional Insights

North America maintains the leading position in the global agrigenomics market, driven by the extensive adoption of genomic technologies for crop and livestock improvement. The region benefits from a well-established research infrastructure and significant investments from major biotechnology firms. Additionally, the United States Department of Agriculture plays a critical role by supporting research initiatives that aim to increase agricultural productivity and disease resistance. This collaborative environment between government bodies and private sector entities fosters continuous development, thereby securing North America's status as the primary contributor to the global market.

Recent Developments

• In November 2024, Computomics and Starke Ayres, a prominent vegetable seed company, entered into a collaboration to enhance crop breeding programs through the use of artificial intelligence. The partnership utilizes Computomics' machine learning-based climate-smart breeding technology to analyze large-scale genomic and environmental data. By modeling complex interactions between genotypes, environments, and management practices, the initiative aims to improve the accuracy of performance predictions for new vegetable varieties. The Research Director at Starke Ayres noted that this data-driven approach would allow breeders to make more informed selection decisions, ultimately accelerating the development of climate-resilient crops.
• In September 2024, Eurofins Agroscience Services announced the acquisition of Verdelab Bioscience, a leading plant pathology laboratory based in Italy. This strategic move expanded Eurofins' capabilities in the seed industry, specifically adding expertise in the detection of fungi, bacteria, viruses, and other plant pests for vegetable breeders. The acquisition was designed to complement existing seed solutions by integrating Verdelab's advanced diagnostic technologies and field experience into Eurofins' global network. By securing this facility, the company aimed to provide a more comprehensive portfolio of integrated solutions, including laboratory testing and bioassays, to agroscience customers across Europe.
• In September 2024, Illumina and LGC Biosearch Technologies announced a strategic partnership to deliver advanced genomic solutions for the agricultural sector in the Asia Pacific and Latin America regions. The collaboration involves combining LGC’s targeted genotyping-by-sequencing library preparation methodology with Illumina’s high-throughput sequencing platforms. This synergy is intended to support plant and animal breeders by increasing sample processing capacity and reducing turnaround times for genetic trait analysis. The partnership focuses on commercializing scalable, cost-effective genotyping workflows that facilitate the development of crops and livestock with improved traits such as disease resistance and higher yields.
• In July 2024, NRGene Canada and the Bühler Group officially opened the North American Insect Center (NAIC) in Saskatchewan, marking a significant milestone in the sector of sustainable protein production. This joint research and demonstration facility was established to optimize the industrial production of insect protein by combining Bühler's advanced processing capabilities with NRGene's genomic expertise. The center enables customers to evaluate the performance of specific Black Soldier Fly varieties on various by-product streams, leveraging genomic data to improve feed conversion rates and protein content. This collaboration aims to accelerate the adoption of insect-based protein as a viable component of the global food system.

Key Market Players

• Illumina, Inc.
• Thermo Fischer Scientific, Inc.
• Agilent Technologies, Inc.
• Eurofins Scientific SE
• LGC Limited
• Tecan Genomics, Inc.
• Neogen Corporation
• Galseq Srl Via Italia
• Biogenetic Services' Inc.

By Purpose	By Sequencer Type	By Application	By Region
DNA Extraction & Purification DNA/RNA Sequencing Genotyping Gene Expression Profiling GMO/Trait Purity Testing Others	Sanger Sequencing Pacbio Sequencers Solid Sequencers Illumina HI SEQ Family Others	Livestock Crops	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Agrigenomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Agrigenomics Market, By Purpose:

• DNA Extraction & Purification
• DNA/RNA Sequencing
• Genotyping
• Gene Expression Profiling
• GMO/Trait Purity Testing
• Others

• Agrigenomics Market, By Sequencer Type:

• Sanger Sequencing
• Pacbio Sequencers
• Solid Sequencers
• Illumina HI SEQ Family
• Others

• Agrigenomics Market, By Application:

• Livestock
• Crops

• Agrigenomics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE